Tilray | TRLY - Acreedores Comerciales

Precio De Mercado
9.15
Cambio Diario
-0.17 -1.82%
Mensual
-6.92%
Anual
1,245.59%
Q2 Expectativa
8.92




Acreedores Comerciales Cambio Fecha
Acasti Pharma USD 459K 881K 2025-09
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Canopy Growth CAD 19.96M 1.83M 2025-12
Cronos Group USD 11.64M 775K 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
IQVIA Holdings USD 3.75B 201M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Moderna USD 317M 50M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Organon & Co USD 1.07B 7M 2025-09
Revvity USD 185.46M 9.66M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12
Zealand Pharma A/S 346.6M 102.71M 2025-12